Warrants And Options (Details 1) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2019 |
Dec. 31, 2018 |
|
| Warrant [Member] | ||
| Number Outstanding | 190,000 | |
| Number Exercisable | 65,000 | |
| Proceeds to Company if Exercised | $ 551,700 | |
| Exercise Price | $ 2.86 | $ 2.33 |
| Warrant One [Member] | ||
| Number Outstanding | 150,000 | |
| Number Exercisable | 25,000 | |
| Proceeds to Company if Exercised | $ 370,500 | |
| Exercise Price | $ 2.47 | |
| Weighted Average Remaining Contractual Life (Years) | 3 years 2 months 30 days | |
| Warrant Two [Member] | ||
| Number Outstanding | 40,000 | |
| Number Exercisable | 40,000 | |
| Proceeds to Company if Exercised | $ 181,200 | |
| Exercise Price | $ 4.53 | |
| Weighted Average Remaining Contractual Life (Years) | 10 months 13 days |
| X | ||||||||||
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|